‘We could eradicate malaria by 2040’ says expert after revolutionary vaccine is approved by WHO
R21/Matrix vaccine was developed by Oxford University together with the Serum Institute of India and can reduce malaria by 75%
Fight against Malaria in Kenya, Horn of Africa threatened by Asian vector
Anopheles Stephensi can transmit multiple parasites, shows high resistance to local insecticides
Malaria: Two groundbreaking vaccines have been developed, but access and rollout are still big stumbling blocks
The demand for malaria vaccine is estimated to be 40-60 million doses by 2026
High-efficacy malaria vaccine manufactured by Serum Institute passes WHO quality checks
R21/Matrix-M malaria vaccine added to the WHO's list of prequalified vaccines
Locally transmitted malaria in the US could be a harbinger of rising disease risk in a warming climate — 5 questions answered
These are first locally transmitted malaria cases in the US since 2003